Genomic organization of the mouse double minute 2 gene

被引:22
作者
Jones, SN
AnsariLari, MA
Hancock, AR
Jones, WJ
Gibbs, RA
Donehower, LA
Bradley, A
机构
[1] BAYLOR COLL MED,DEPT MOL VIROL,HOUSTON,TX 77030
[2] BAYLOR COLL MED,HOWARD HUGHES MED INST,HOUSTON,TX 77030
关键词
Mdm2; activating mutations; gene structure; transcription initiation;
D O I
10.1016/0378-1119(96)00151-5
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Transfection of the mouse double minute 2 (Mdm2) oncogene has been found to induce immortalization of primary cells and to transform cultured cells. Amplification and/or overexpression of human MDM2 has been documented in a large percentage of human cancers. Mouse and human Mdm2 cDNA have been cloned from transformed cells and the cDNA sequence of both genes have been reported previously. In this report, we present the gene structure of mouse Mdm2. Comparison of the coding sequences of the Mdm2 gene with the previously reported cDNA sequence and with Mdm2 sequences obtained from an Mdm2-bearing cosmid clone capable of inducing transformation revealed that the reported cDNA sequence was in error, and that Mdm2-induced transformation of cells does not require an activating mutation in Mdm2. Ligation-anchor PCR analysis of transcripts produced from the P1 and P2 promoters indicates that transcription initiates at sites upstream of those reported previously for both promoters.
引用
收藏
页码:209 / 213
页数:5
相关论文
共 17 条
[1]   REGULATION OF MDM2 EXPRESSION BY P53 - ALTERNATIVE PROMOTERS PRODUCE TRANSCRIPTS WITH NONIDENTICAL TRANSLATION POTENTIAL [J].
BARAK, Y ;
GOTTLIEB, E ;
JUVENGERSHON, T ;
OREN, M .
GENES & DEVELOPMENT, 1994, 8 (15) :1739-1749
[2]  
BUESORAMOS CE, 1993, BLOOD, V82, P2617
[3]   REGULATION OF TRANSCRIPTION FUNCTIONS OF THE P53 TUMOR-SUPPRESSOR BY THE MDM-2 ONCOGENE [J].
CHEN, JD ;
LIN, JY ;
LEVINE, AJ .
MOLECULAR MEDICINE, 1995, 1 (02) :142-152
[4]   TUMORIGENIC POTENTIAL ASSOCIATED WITH ENHANCED EXPRESSION OF A GENE THAT IS AMPLIFIED IN A MOUSE-TUMOR CELL-LINE [J].
FAKHARZADEH, SS ;
TRUSKO, SP ;
GEORGE, DL .
EMBO JOURNAL, 1991, 10 (06) :1565-1569
[5]   THE MDM-2 ONCOGENE CAN OVERCOME WILD-TYPE P53 SUPPRESSION OF TRANSFORMED-CELL GROWTH [J].
FINLAY, CA .
MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (01) :301-306
[6]  
HARVEY M, 1993, ONCOGENE, V8, P2457
[7]   PROMOTER REGION OF THE HUMAN HARVEY RAS PROTO-ONCOGENE - SIMILARITY TO THE EGF RECEPTOR PROTO-ONCOGENE PROMOTER [J].
ISHII, S ;
MERLINO, GT ;
PASTAN, I .
SCIENCE, 1985, 230 (4732) :1378-1381
[8]  
JUVEN T, 1993, ONCOGENE, V8, P3411
[9]  
KOZAK M, 1991, J BIOL CHEM, V266, P19867
[10]   STIMULATION OF E2F1/DP1 TRANSCRIPTIONAL ACTIVITY BY MDM2 ONCOPROTEIN [J].
MARTIN, K ;
TROUCHE, D ;
HAGEMEIER, C ;
SORENSEN, TS ;
LATHANGUE, NB ;
KOUZARIDES, T .
NATURE, 1995, 375 (6533) :691-694